Veradigm Inc (MDRX)
Market Cap | 1.07B |
Revenue (ttm) | n/a |
Net Income (ttm) | n/a |
Shares Out | 107.64M |
EPS (ttm) | 0.86 |
PE Ratio | 11.51 |
Forward PE | 6.53 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 24,526 |
Open | 9.65 |
Previous Close | 9.65 |
Day's Range | 9.65 - 9.90 |
52-Week Range | 5.01 - 14.09 |
Beta | 0.63 |
Analysts | Buy |
Price Target | 12.00 (+21.21%) |
Earnings Date | Mar 12, 2024 |
About MDRX
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR softwa... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for MDRX stock is "Buy." The 12-month stock price forecast is $12.0, which is an increase of 21.21% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/1/z/press3-2475386.jpg)
Black Book ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solutions Vendor in 2024
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market r...
![](https://cdn.snapi.dev/images/v1/6/h/press12-2472288.jpg)
The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX)
Investors can contact the law firm at no cost to learn more about recovering their losses.
![](https://cdn.snapi.dev/images/v1/2/g/press14-2469297.jpg)
Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
SAN DIEGO--(BUSINESS WIRE)---- $MDRX #IPO--Robbins LLP is Investigating Allegations Veradigm Inc. (MDRX) Violated Securities Laws in Connection with Misstatements in Financial Reporting.
![](https://cdn.snapi.dev/images/v1/q/k/press10-2460196.jpg)
Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Veradigm Inc. (OTC: MDRX) to determine whether certain Veradigm officers and directors violated se...
![](https://cdn.snapi.dev/images/v1/i/i/press3-2453511.jpg)
Veradigm Payerpath Rated Highest in Client Satisfaction
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and ...
![](https://cdn.snapi.dev/images/v1/l/u/press16-2449460.jpg)
Veradigm Announces Leadership Updates
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of healthcare data and technology solutions, today announced that, on June 7, 2024, Tom Langan, t...
![](https://cdn.snapi.dev/images/v1/j/p/press17-2449462.jpg)
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of healthcare data and technology solutions, today announced that it has initiated a process to e...
![](https://cdn.snapi.dev/images/v1/y/x/press15-2435033.jpg)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announces that it has commenced an investigation of potential claims against th...
![](https://cdn.snapi.dev/images/v1/p/e/press2-2432832.jpg)
Law Offices of Howard G. Smith Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it has commenced an investigation of potential claims against the board of directors of Veradigm Inc. (“Veradigm” or the “...
![](https://cdn.snapi.dev/images/v1/9/b/press10-2430866.jpg)
The Law Offices of Frank R. Cruz Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) concerning whether the board of directors breach...
![](https://cdn.snapi.dev/images/v1/9/8/press7-2399913.jpg)
MedEvolve Announces Strategic Marketing Relationship with Veradigm to Enhance Revenue Cycle Management Solutions for Healthcare Organizations
LITTLE ROCK, Ark.--(BUSINESS WIRE)--MedEvolve, a leading provider of effective intelligence technology that provides, automation, transparency and accountability for the healthcare revenue cycle, is p...
![](https://cdn.snapi.dev/images/v1/x/e/press18-2362885.jpg)
Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book, a healthcare-centric market research a...
![](https://cdn.snapi.dev/images/v1/0/f/press12-2354034.jpg)
Veradigm and Vim to Improve Payer-Provider Collaboration
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced its strategic collaboration with Vim, a leading middleware pla...
![](https://cdn.snapi.dev/images/v1/u/t/press5-2341773.jpg)
Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation
SAN DIEGO , March 26, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc., f.k.a. Allscripts Healthcare Solutions, Inc. In...
![](https://cdn.snapi.dev/images/v1/h/u/press1-2325420.jpg)
Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho, Veradigm Interim Chief Executive Of...
![](https://cdn.snapi.dev/images/v1/h/l/press1-2321802.jpg)
Veradigm Announces Initial Financial Guidance for Fiscal 2024
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today it has reaffirmed the estimated, unaudited ranges f...
![](https://cdn.snapi.dev/images/v1/p/r/press14-2307148.jpg)
Veradigm Completes Acquisition of ScienceIO
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has completed ...
![](https://cdn.snapi.dev/images/v1/e/z/press7-2298039.jpg)
Veradigm to Participate in TD Cowen Annual Health Care Conference
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief...
![](https://cdn.snapi.dev/images/v1/x/t/press13-2298049.jpg)
Veradigm Receives Expected Delisting Notice from Nasdaq
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice...
![](https://cdn.snapi.dev/images/v1/c/p/press1-2295371.jpg)
Veradigm to Acquire ScienceIO
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has signed a de...
![](https://cdn.snapi.dev/images/v1/p/i/press2-2295372.jpg)
Veradigm Provides Update on its Financial Restatement Process
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, announced today that the Company does n...
![](https://cdn.snapi.dev/images/v1/r/q/press5-2288342.jpg)
Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will be highlighting the new Veradigm Payer ...
![](https://cdn.snapi.dev/images/v1/h/z/press14-2283327.jpg)
Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.
CHICAGO--(BUSINESS WIRE)-- #healthIT--Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to this analysis on cardiovascular...
![](https://cdn.snapi.dev/images/v1/l/s/press8-2273224.jpg)
Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of C...
![](https://cdn.snapi.dev/images/v1/4/j/press16-2262218.jpg)
Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation
SAN DIEGO , Feb. 6, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc. (NASDAQ: MDRX) shares. Investors, who purchased sh...